2) Liposomal Prostaglandin E_1
前列腺素E_1脂微球载体制剂
1.
Effect of Liposomal Prostaglandin E_1 on Kidney Function during Cardiopulmonary Bypass;
前列腺素E_1脂微球载体制剂对围体外循环期患者肾功能影响的观察与研究
2.
Effect of Liposomal Prostaglandin E_1 on Kidney Function During Cardiopulmonary Bypass;
目的：观察前列腺素E_1脂微球载体制剂(liposomal prostaglandin E_1，lipo-PGE_1)对心脏瓣膜置换术患者围体外循环(cardiopulmonary bypass，CPB)期肾功能的影响并探讨其可能的机制。
3) Prostaglandin E_1
前列腺素E_1
1.
The Use of Prostaglandin E_1 During Off-pump Coronary Artery Bypass Grafting in Patients of Old Age;
前列腺素E_1在老年患者非体外循环冠状动脉旁路移植术中的应用
2.
Effect of prostaglandin E_1 on monocyte chemotactic protein-1 expression in Kupffer cells of rats with hepatic ischemia-reperfusion injury;
前列腺素E_1对肝缺血/再灌注损伤大鼠Kupffer细胞中单核细胞趋化蛋白-1表达的影响
3.
Study of prostaglandin E_1 combined with Low Molecular Heparin on old patients with cardiac failure caused by coronary heart disease;
前列腺素E_1联合低分子肝素治疗老年冠心病心力衰竭的研究
5) PGE_1
前列腺素E_1
1.
Efficacy and safety of PGE_1 in adults with viral icterohepatitis;
前列腺素E_1治疗病毒性肝炎患者高胆红素血症的疗效和安全性
2.
Clinical study on the effects of PGE_1 injection in patients with hepatorenal syndrome;
前列腺素E_1治疗肝肾综合征的临床研究
3.
Clinical efficacy observation of treatment with PHGF combined with PGE_1 on chronic severe hepatits B;
促肝细胞生长素联合前列腺素E_1治疗慢性乙型重型肝炎疗效观察
6) PGE1
前列腺素E_1
1.
Objectives To observe the efficacy and safety of PGE1 in the treatment of viral hepatitis with intrahepatic biliary stasis.
目的 观察前列腺素E_1治疗肝内胆汁淤积性病毒性肝炎疗效。
2.
Objective:To determine the effect of intravascular administration of PGE1 onmyocardial angiogenesis and the expression of VEGF in rats with acute myocardialinfarction,and the relationship between the dose of PGE1 and effect of the expressionof VEGF in rat cardiac myocytes.
目的:探讨前列腺素E_1(PGE_1)对急性心肌梗死(AMI)大鼠心肌血管生成及血管内皮生长因子(VEGF)表达的影响,以及PGE_1剂量与心肌细胞分泌血管内皮生长因子之间的初步量效关系。
补充资料：可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前，把二者注入靶动脉，可暂时减少动脉血流，再行化疗药物灌注，以减少血液冲刷，保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同，DSM和BAM仅造成数十分钟的血流量减少，待其被降解后血流可恢复至以前水平。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条